| 8th Dec 2020 2:42 pm |
RNS |
Result of Annual General Meeting |
| 20th Nov 2020 1:51 pm |
RNS |
Grant of Awards under Long Term Incentive Plan |
| 20th Nov 2020 7:00 am |
RNS |
Director/PDMR Shareholding |
| 10th Nov 2020 7:05 am |
RNS |
Annual Report & Accounts and AGM Notification |
| 26th Oct 2020 7:00 am |
RNS |
Initiation of Grass MATA MPL exploratory study |
| 12th Oct 2020 7:00 am |
RNS |
Holding(s) in Company |
| 9th Oct 2020 7:00 am |
RNS |
Director Dealings and Issue of Equity |
| 23rd Sep 2020 7:00 am |
RNS |
Preliminary Results |
| 3rd Sep 2020 7:00 am |
RNS |
AGY secures VLP technology platform |
| 20th Jul 2020 7:30 am |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): Record sales and a COVID-19 wildcard |
| 15th Jul 2020 11:05 am |
RNS |
Second Price Monitoring Extn |
| 15th Jul 2020 11:00 am |
RNS |
Price Monitoring Extension |
| 15th Jul 2020 7:00 am |
RNS |
Trading Update |
| 9th Jul 2020 7:00 am |
RNS |
Invalidation of Birch MATA MPL phase III results |
| 1st Jul 2020 5:15 pm |
RNS |
Total Voting Rights |
| 1st Jul 2020 5:14 pm |
RNS |
BLOCK LISTING SIX MONTHLY RETURN |
| 24th Jun 2020 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 24th Jun 2020 4:36 pm |
RNS |
Price Monitoring Extension |
| 24th Jun 2020 7:00 am |
RNS |
Trading Update |
| 18th May 2020 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 18th May 2020 2:00 pm |
RNS |
Price Monitoring Extension |
| 23rd Apr 2020 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 23rd Apr 2020 4:36 pm |
RNS |
Price Monitoring Extension |
| 22nd Apr 2020 10:11 am |
RNS |
EAACI review of adjuvants and formulations |
| 1st Apr 2020 1:09 pm |
RNS |
Grant and Vesting of Awards |
| 9th Mar 2020 7:15 am |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): Consistent first-half revenue growth |
| 4th Mar 2020 7:00 am |
RNS |
Half-year Report |
| 29th Jan 2020 12:00 pm |
RNS |
Data for peanut allergy vaccine published in JACI |
| 16th Jan 2020 12:25 pm |
RNS |
Trading Update & Notice of Results - Replacement |
| 16th Jan 2020 8:00 am |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): Sales growth well above market average |
| 16th Jan 2020 7:00 am |
RNS |
Half Year Trading Update & Notice of Results |
| 2nd Dec 2019 9:57 am |
RNS |
Holdings in Company |
| 29th Nov 2019 10:34 am |
RNS |
Holdings in Company |
| 26th Nov 2019 7:00 am |
RNS |
Update to Grass MATA MPL Ph III clinical programme |
| 25th Nov 2019 12:13 pm |
RNS |
Result of Annual General Meeting |
| 22nd Oct 2019 9:23 am |
RNS |
Annual Report and Accounts |
| 26th Sep 2019 7:30 am |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): Continuing to gain market share |
| 25th Sep 2019 7:00 am |
RNS |
Preliminary Results |
| 11th Jul 2019 7:00 am |
RNS |
Trading update |
| 1st Jul 2019 7:21 am |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): Successful legal outcome removes uncertainty |
